Rowena Holland

Rowena Holland is an accomplished executive with extensive experience in market access, pricing, and reimbursement strategies within the pharmaceutical industry. Currently serving as Vice President of International Portfolio Strategy & Pricing, Reimbursement & Market Access at Jazz Pharmaceuticals, Holland has a proven track record of success in previous roles, including Vice President Market Access & HEOR at GW Pharmaceuticals, where expertise in developing pricing and reimbursement strategies for Epidyolex contributed to significant achievements across international markets. At Intercept Pharmaceuticals, Holland led global market access and HEOR efforts, facilitating geographical expansion and enabling profitable commercial access. Notable early career achievements include establishing the global pricing and reimbursement strategy at Gilead Sciences, which set industry standards and drove record revenue growth. Holland holds a PhD and MBA in Biochemistry from the University of Warwick - Warwick Business School.